Mundipharma announces exclusive distribution agreement with Janssen for two primary care diabetes treatments Invokana®(canagliflozin) and Vokanamet®(canagliflozin /metformin) for selected European countries

Sep 04 2017

For European medical and pharmaceutical media only| PDF iconDownload PDF